peoplePerson
Maximilian Diehn
Radiation oncologist who showed a blood test can detect leftover lung cancer months before scans.
Physician-scientist who co-developed CAPP-Seq with Ash Alizadeh and demonstrated ctDNA-based minimal residual disease detection after curative lung cancer treatment. Studies radiation biology and personalised radiotherapy.
Role
Professor of Radiation Oncology, Stanford University
Specialisms
Radiation oncologyCirculating tumour DNALung cancer
| Title | Journal | Year |
|---|---|---|
| Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling | Cancer Discovery | 2017 |
| Integrating genomic features for non-invasive early lung cancer detection | Nature | 2020 |